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Abstract 
Vortical blood flow in the human left ventricular (LV) inflow initiates from the mitral valve (MV) and evolves 
within the LV during diastolic E-filling. Hence, vortical flow links MV and LV hemodynamics. This study 
sought to elucidate and quantitatively characterize the in vivo 3D dynamics of LV vortical flow over E-
filling and relation to MV-LV hemodynamic coupling using 4D Flow MRI flow field. 34 healthy volunteers 
and 5 example patients underwent 4D Flow MRI. Vortical blood flow evolution was mapped in the LV over 
E-wave using enstrophy density. A new dimensionless profile PMV-LV was derived as a function of both MV 
vortex formation time (VFT) and LV volumetric enstrophy density. Results reveal that 3D vortical flow 
evolution in the healthy LV follows a bi-phasic behavior with a vortical growth phase followed by a vortical 
decay phase. In healthy LVs studied, the PMV-LV profile showed that the vortical growth and decay phases 
are characterized by a vortical growth time 𝑇௚௥௢௪௧௛ ൌ  1.23 േ 0.25, growth rate 𝛼 ൌ 0.80 േ 0.17, decay time 
𝑇ௗ௘௖௔௬ ൌ  0.96 േ 0.39 and decay rate 𝛽 ൌ െ1.02 േ 0.49. Distinctly altered parameters were found in the 
pilot patients studied.  The derived  
PMV-LV profile quantitatively characterizes MV-LV hemodynamic coupling by vortical flow dynamics. 
Results herein unravel new insights into cardiac physiology and could enable a novel standardized 
methodology to study MV-LV hemodynamic coupling and association to cardiac function in health and 
disease.  
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Introduction 
 In-vivo and in-vitro studies have shown that the inflow of blood into the human heart’s 
left ventricle (LV) during E-filling provokes a swirling motion forming distinct vortical flow 
patterns (1-6). LV vortical flow is thought to help to preserve momentum, minimize kinetic 
energy loss and to help redirecting mitral inflow blood towards the aortic outflow tract (2, 6, 7). 
The formation of vortical flow in the human heart has been extensively studied in-vivo and in-
vitro (2-5, 7, 10-13). Altered vortical flow formation was reported in patients with congenital and 
acquired heart disease (1, 5, 8, 9) and was recently associated to elevated levels of intra-
cardiac viscous energy loss (7, 10). Nevertheless, the role of vortical blood flow in cardiac 
(patho)physiology is not yet fully understood and remains a subject of debate in the literature 
(11-13). 
 Earlier studies have shown that diastolic vortical flow initiates, with the start of the E-
filling, from the shear layers distal to the mitral valve (MV) leaflets as a result of MV inflow 
interaction with the MV geometry.  Thus, vortical flow formation has been characterized as a 
function of MV geometry and inflow dynamics (1, 5, 14, 15). However, such characterization 
implies that LV vortical flow is uni-phasic dominated by vortical flow formation from the MV and 
does not take into account the impact of the dynamic LV geometry on vortical flow. Recent 
studies have shown that the formed vortical flow continues to evolve within the dynamic LV 
geometry over diastole resulting in time-varying vortical flow patterns (3, 4, 16, 17). Thus, 
suggesting an impact of the dynamic LV geometry on the evolution of vortical flow. While 
previous studies have provided a better understanding of the LV vortical flow formation 
phenomenon (1, 4-6, 16, 17), there is currently a lack of quantitative methods for characterizing 
or mapping of the time-evolution of vortical flow within the dynamic LV geometry of healthy 
subjects and patients. As a result, the actual in vivo evolution of vortical flow in the LV over E-
filing remains unclear. 
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 Given that vortical flow, during E-filling, emerges from MV inflow dynamics but 
progresses inside the LV bounded by its dynamics geometry (1, 3, 4), we hypothesized that 
vortical flow evolution would be determined as a function of both MV and LV dynamics (i.e. is a 
reflection of the coupled dynamics between MV and LV). Therefore, characterization of the 3D 
intra-cardiac vortical flow evolution during E-filling could allow deriving a novel method to assess 
MV-LV hemodynamic coupling in the presence of normal and pathologic valvular and ventricular 
dynamics.  
 In this work, we aimed to employ 4D Flow MRI to 1) Elucidate the dynamics of vortical 
flow within the human LV over E-filling in healthy subjects 2) Derive a standardized quantitative 
profile characterizing the MV-LV hemodynamic coupling during E-filling using 3D vortical flow 
evolution. 3) Probe the feasibility of the derived profile in detecting differences between healthy 
subjects and five pilot patients with various MV and LV abnormalities. 
 
 
Materials and Methods 
Study Population 
The study was conducted across two centers, Leiden University Medical Center, the 
Netherlands and University of Leeds, UK, and was approved by the institutional Medical Ethical 
Committee in Leiden and the National Research Ethics Service in Leeds. Written informed 
consents were obtained from all participants or their parents.  
A total of 39 subjects were retrospectively enrolled in this study; 34 healthy volunteers (age 
27±16 years) and 5 example patients as representatives of valvular and/or ventricular disease: 
a hypertrophic cardiomyopathy (HCM) patient, a patient with restricted MV opening, a patient 
with remodeled LV manifested in LV dilation after myocardial infarction (MI), a patient with a 
presentation of both MV restriction and LV dilation, and a dilated cardiomyopathy (DCM) patient. 
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These patients were chosen to show the feasibility of the derived method in detecting 
differences in the presence of example MV and LV abnormalities compared to the studied 
healthy volunteers. 
 
MRI acquisition 
All subjects underwent whole-heart 4D Flow MRI on a 3T or 1.5T MRI scanner (Philips 
Healthcare, Best, The Netherlands) using a combination of FlexCoverage Posterior coil in the 
table top with a dStream Torso coil, providing up to 32 coil elements for signal reception. 
Velocity encoding (VENC) of 150cm/s was used in all three directions, with reconstructed spatial 
resolution of 2.3mm×2.3mm×(3.0mm-4.2mm), flip angle 10°, echo time (TE) 3.2ms and 
repetition time (TR) 7.7ms, resulting in a maximal true temporal resolution of 4×TR=31ms. 
Retrospective ECG-gating was used and 30 cardiac phases were reconstructed to represent 
one average heartbeat. To accelerate acquisition, parallel imaging SENSE with factor 2 was 
used and echo planar imaging with factor 5. To allow a reasonable acquisition time (8-10 
minutes), free breathing was allowed for both patients as well as controls. Standard short-axis 
anatomical MRI cine data was as also acquired. A typical volume for a whole-heart 4D Flow 
MRI acquisition was 396 mm (right-left) × 336 mm (anterior-posterior) × 117 mm (feet-head). 
Concomitant gradient correction and local phase correction were applied using the software 
available on the MRI system. For more details on the MRI protocol, readers are referred to our 
previous publications (4, 7, 8). 
 
Image analysis workflow 
 Using in-house developed MASS software (Leiden University Medical Center), the LV 
endocardial contours were segmented from 4D Flow MRI as previously described (7). In short, 
to tackle the typical low contrast in 4D Flow MRI that makes its LV segmentation challenging, 
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LV contours were first manually traced on anatomical short-axis slices over all acquired time 
phases. Contours were then projected on the whole-heart 4D Flow data. To reduce possible 
translation and rotation errors between cine short-axis and whole-heart 4D Flow acquisitions, 
automated image registration by mutual information using Elastix (18) was performed between 
cine short-axis data and velocity magnitude reconstructed images of the 4D Flow data using a 
single phase that visually showed the best depiction of the LV in the velocity magnitude 4D Flow 
image. Registration was restricted to translation and rotation. The resulted transformation matrix 
was then propagated to all 4D Flow phases. The 3D velocity field data within the segmented 4D 
Flow LV volume was then used to compute enstrophy parameters as described below. 
Segmented LV endocardial boundaries were also used to compute the LV end-diastolic volume 
(EDV), end-systolic volume (ESV), stroke volume (SV) and ejection fraction.  
 Retrospective mitral valve tracking was used to quantify inflow and derive flow-time 
curves from the 4D flow data as previously described (19). The time points corresponding to 
start of E-filling, peak early filling (E-peak) and end of E-filling were defined from the flow-time 
curves. For further details on our used image analysis framework and workflow, readers are 
referred to our previous publications (4, 7). 
 
Computation of vortical flow strength by enstrophy maps from 4D Flow MRI 
 4D Flow MRI-derived velocity field was used to compute maps of the local strength of 
the vortical blood flow in the LV quantified in terms of voxel-wise enstrophy maps. Enstrophy is 
the squared magnitude of the vorticity vector and thus can be computed directly from velocity 
gradients obtained from in-vivo 4D Flow MRI. Enstrophy is an important fluid mechanics 
quantity as it provides a measure of the local strength of rotational motion in the flow and has 
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been used to characterize the evolution of a variety of vortical flows and quantify energy 
dissipation (20).  
4D Flow MRI provides in-vivo measurements of the three-directional velocity field 𝑉ሺ𝑢, 𝑣, 𝑤ሻ, in 
the three principal directions 𝑥, 𝑦, 𝑧 and over the complete cardiac cycle (18). Given the acquired 
velocity field, the enstrophy (𝜖) at a voxel (i,j,n) in the domain of interest (segmented LV volume) 
at time instance 𝑡 can be computed from the Vorticity (𝜔) field   
𝜖௜,௝,௡ሺ𝑡ሻ ൌ  ଵଶ 𝜔௜,௝,௡ଶ ሺ𝑡ሻ, 𝜔 = ቀ
డ௪
డ௬ െ
డ௩
డ௭ ,
డ௨
డ௭ െ
డ௪
డ௫ ,
డ௩
డ௫ െ
డ௨
డ௬ቁ , 𝑖 ൌ 1: 𝑋; 𝑗 ൌ 1: 𝑌 𝑎𝑛𝑑 𝑛 ൌ 1: 𝑁       [1] 
With 𝑋 as the image width, 𝑌 as the image height and 𝑁 as the number of slices. This provides 
an enstrophy map at time instance 𝑡 over the segmented LV volume.  
 
Computation of instantaneous total enstrophy in the LV (TEDLV) over E-filling 
To quantify the overall evolution of LV vortical flow patterns, we introduce the instantaneous 
non-dimensional Total (volume-integrated) Enstrophy Density (TEDLV) derived as follows:  
The total enstrophy (𝐸௧) at time instance 𝑡 over the 3D segmented LV volume of 𝑀 voxels and 
with voxel size 𝐿 is computed as: 
𝐸௧ ൌ ∑ 𝜖௞ሺ𝑡ሻெ௞ୀଵ 𝐿  ሾm3/s2ሿ        ሾ2ሿ 
such that 𝑡 ൌ 0 ∶ 𝑇 correspond to the acquired 4D Flow MR time frame that are spanning from 
the start of E-filling ሺ𝑡 ൌ 0ሻ to the end of E-filling by the end of diastasis ሺ𝑡 ൌ 𝑇ሻ. This results in a 
profile curve representing the dynamic evolution of total enstrophy in the LV over E-filling. Since 
our control volume (the LV volume) changes dynamically over the cardiac cycle, we use the 
spatially-averaged enstrophy density to account to this volumetric variability (20). Accordingly, 
volume-normalized enstrophy density (𝑅) is defined as:  
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𝑅௧ ൌ ா೟௩௢௟ሺ௅௏೟ሻ    ሾ1/s2ሿ         [3] 
such that 𝑣𝑜𝑙ሺ𝐿𝑉௧ሻ  is the volume of the segmented LV region of interest at acquired time frame 
𝑡. Of note, 𝑅௧ computation involves normalization by instantaneous LV volumes. Therefore, it 
accounts for the potential difference in LV size between different subjects and also takes into 
consideration the LV size change over the diastolic filling of the same subject. 
To further enable a standardized analysis over different subjects, it is best to evaluate vortical 
flow profile in a standardized dimensionless means. Therefore, to account for subject-specific 
variability of the vorticity field, the so obtained enstrophy integral (𝑅௧) is normalized by the time-
peak enstrophy for this individual over the entire E-filling process (i.e. instantaneous TEDLV 
values are time-normalized relative to time-peak TEDLV — time-peak TEDLV has normalized to 
1): 
𝑇𝐸𝐷௅௏ሺ𝑡ሻ ൌ  ோ೟୫ୟ୶భರೝರ೅ ோೝ, 𝑡 ൌ 0: 𝑇, [dimensionless]   [4]   
𝑇 is number of acquired E-filling phases as described above. Using this normalization approach 
allows standardized comparison of 𝑇𝐸𝐷௅௏ between different patients.  
 
Construction of standardized MV-LV vortical flow evolution profile (PMV-LV) 
To quantify vortical flow dynamics in the LV over E-filling and to link to both MV and LV 
hemodynamics, we constructed a temporal vortical flow profile (PMV-LV) as a function of both MV 
and LV vorticity dynamics over E-filling. The dimensionless profile PMV-LV is constructed from 
Equation 4 and 5 by plotting LV enstrophy density evolution (TEDLV) as the y-axis relative to the 
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temporal vorticity discharge rate from MV by means of the dimensionless temporal vortex 
formation time (𝑇ெ௏) as the X-axis.  Following (15), 𝑇ெ௏ is computed as: 
  𝑇ெ௏೟ ൌ ׬ ௎஽
௭
଴  𝑑𝑡, 𝑧 ൌ 𝑡 ∗ 𝛥𝑡, t ൌ 0: T [dimensionless]  [5] 
 𝛥𝑡 is the temporal resolution of acquired 4D Flow MRI, 𝑈 is the instantaneous inflow velocity 
through the MV and 𝐷 as maximum diameter of mitral inflow opening. D was computed at E-
peak from the area of the MV flow on retrospective valve tracking (19) at peak inflow velocity 
level (i.e., approximately at the tip of the valves), assuming a circular inflow area. In the original 
definition, D=constant. However in our case, we use D = D(t) since the valve opens and closes 
over E-filling. This is similar to the concept used by Gharib et al in (1) with D defined as the 
maximum MV inflow diameter over E-wave. We used the maximum diameter (Dmax) instead of 
average diameter as in (1) because we estimate MV dimeter from flow data in which MV region 
can be unclear near to diastasis when little or no inflow is present. As such, using Dmax assures 
more reliable measurement of MV diameter derived from 4D Flow MRI. 
As such, PMV-LV characterizes the MV and LV hemodynamic coupling through vortical flow 
dynamics by linking the enstrophy density derived from LV vorticity dynamics to the vortex 
formation time derived from MV vorticity dynamics. Note that PMV-LV is a dimensionless profile. 
Thus, facilitates standardized comparison of MV-LV hemodynamic coupling between different 
patients. 
All enstrophy analyses were performed using an in-house software module developed using 
MATLAB (MathWorks Inc.). 
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Statistical Analysis 
Data analysis was performed using SPSS Statistics (version 20.0 IBM SPSS, Chicago, IL). 
Variables were tested for normal distribution using the Shapiro-Wilk test. P<0.05 was 
considered statistically significant. Continuous variables are expressed as mean ± standard 
deviation (SD) or as median with inter-quartile range (IQR) where appropriate. 
 
Table 1. Characteristics of healthy volunteers and patients. 
 Healthy 
volunteers 
(N=34) 
DCM 
patient 
 
HCM 
patient 
MI 
patient 
Restricted Mitral 
valve patient with 
normal size LV 
Restricted Mitral 
valve patient 
with dilated LV 
size 
Age, years 27±16 73 65 71 12 16 
Sex 
(Female(F)/Male(M)) 
16 F M F M F F 
Heart rate, bpm 68±17 64 90 80 114 60 
LVEDV( ml) 147±40 279 147 200 129 215 
LVESV (ml) 57±19 226 79 138 62 92 
SV (ml) 90±23 53 67 61.5 67 123 
BMI (kg/m2) 21±4 26 24 33.8 44 29 
LV Mass (g) 83±24 130 121 104 68 91 
Ejection Fraction, % 62±4 19 46 30.8 52 57 
MV peak inflow area 
(cm2) 
9.66±2.47 14.91 5.66 17.95 5.58 5.17 
LV= Left Ventricle, LVEDV= Left Ventricular End Diastolic Volume, LVESV= Left Ventricular End Systolic 
Volume, SV=Stroke Volume, BMI=Body Mass Index, DCM= LV Dilated Cardiomyopathy, HCM=LV Hypertrophic 
Cardiomyopathy. MI=Myocardial Infarction, ± refers to standard deviation 
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Results 
Clinical Characteristics 
Clinical characteristics of the studied subjects are summarized in Table 1. 
 
Bi-phasic vortical flow process regulated by MV-LV hemodynamic coupling 
 
 Figure 1, and Supplementary Video 1, show an example of the 4D Flow MRI-derived 
instantaneous enstrophy maps, computed over all E-filling frames (12-frames) of the acquired 
30 time-frame cine 4D Flow MRI in a 29-year-old male visualized in a 4 chamber and (mid-) 
basal short axis cross-sectional views. The overall evolution of large-scale vortical flow patterns 
in the LV over diastole as revealed by the enstrophy maps in Figure 1 was found to be 
consistent among all the studied healthy subjects. With the start of MV opening, vortical flow 
(marked by the regions of high enstrophy density) emerges distally to the mitral valve near the 
leaflets tip. Consistent with previous reports, this vortical flow continues to grow while organizing 
into a ring-like structure near to the moment of the peak E-filling (1, 3-5, 14). However, following 
peak E-filling, this vortex ring propagates at an inclined angle towards the LV free wall giving 
rise to vortex-wall interaction. At a time point past-peak E-filling, the vortex ring flow starts to 
decay becoming disorganized as it gradually loses its distinct ring-like shape. We note that this 
apparent decay phase of the vortex ring emanating from the MV has not been reported before 
in-vivo though it has been postulated by numerical simulation (3).  
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Figure 1: Vortical flow evolution in the LV over E-wave by means of enstrophy maps in a healthy 29-year-old volunteer: 
Enstrophy maps are color coded from blue (minimum) to red (maximum). Presented enstrophy values are dimensionless 
(normalized to temporal peak enstrophy value). For each acquired E-wave time-phase, from the computed 3D enstrophy maps, 
two standard cross-sectional views are presented: a four-chamber view (on the left) and next to it is a short-axis view (on the 
right) at the mid-basal level highlighted by the dotted red line. The curve on bottom left represents the MV inflow rate from 
which the start and end of filling phases are derived. The dots represent the acquired 4D Flow MRI time-phases. In this subject, 
E-filling is defined from start of E-filling at time-point (f1) until the end of diastasis at time-point (f12). The profile on the bottom 
right shows the derived dimensionless PMV-LV profile corresponding to this subject. 
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The enstrophy in the flow continues to decay during E-inflow deceleration until it essentially 
diminishes by the end of diastasis (Figure 1). No pockets of intense vorticity (high enstrophy 
levels) are seen to be able to reach the apex by the end of the E-wave. These results show that 
MV inflow dynamics gives rise to the formation of the vortical flow (including vortex ring) and 
impacts its growth (1, 3, 4) while the LV wall dynamics governs its subsequent decay. 
Therefore, this supports our hypothesis that vortical flow evolution in the LV is not only a 
function of MV inflow but rather regulated by a hemodynamic coupling between MV inflow and 
LV wall geometry dynamics.  
 
Standardized dynamic vortical flow profile (PMV-LV) and its characteristic parameters 
 Figure 2a shows a representative example of the dynamic vortical profile PMV-LV of a 
healthy volunteer and presents definitions of the derived characteristic parameters. Table 2 
presents the results of the derived characteristic parameters over all studied healthy subjects. In 
line with our reported vortical flow evolution by enstrophy mapping above, the derived PMV-LV 
profile of all healthy subjects (Figure 2a, 2b) exhibits two distinct phases: the vortical flow growth 
phase and the vortical flow decay phase. The vortical flow growth phase starts with the opening 
of MV generating enstrophy along the shear layers emanating from the MV leaflets (Figure 1). 
The TEDLV reaches its peak at a dimensionless vortical formation time 𝑇௚௥௢௪௧௛= 1.23 േ 0.25 with 
a growth rate (slope) 𝛼 ൌ 0.80 േ 0.17, which marks the end of the vortical growth phase. 
Following the peak, the TEDLV starts to decay, as vortex structures begin to interact with the LV 
wall (see Figure 1), with total decay time 𝑇ௗ௘௖௔௬ ൌ 0.96 േ 0.39 and decay rate (slope) 𝛽 ൌ
െ1.02 േ 0.49. Note that at the start of inflow discharge, the value of TEDLV was 𝑇𝐸𝐷௦௧௔௥௧ ൌ 14 േ
9% of the time-peak TEDLV value while at the end of E-filling 𝑇𝐸𝐷௘௡ௗ ൌ 18 േ 9% of the time-
peak TEDLV value. 
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Figure 2: Parameterized dimensionless temporal vortical blood flow profile (PMV-LV) (a) An example temporal PMV-LV 
profile of a healthy volunteer demonstrates the different characteristic parameters of the evolution of total dimensionless 
enstrophy in the LV over the dimensionless vortex formation time(T୑୚). From the enstrophy evolution curve two main phases 
are defined, the vortical formation phase can be characterized by the following parameters: the non-dimensionless vortical 
growth duration 𝑇௚௥௢௪௧௛, the enstrophy growth rate α and 𝐸௦௧௔௥௧ which is the enstrophy level in the LV at the start of MV 
discharge as percentage of the time-peak enstrophy level. The vortical decay phase can be characterized by the three parameters: 
the non-dimensionless duration of vortical flow decay 𝑇ௗ௘௖௔௬, the enstrophy decay rate β and 𝐸௘௡ௗ which is enstrophy level in the 
LV at the end of E-filling as percentage of the time-peak enstrophy level. (b) shows the significantly altered PMV-LV profiles in the 
5 sample cardiac patients studied (in color) compared to PMV-LV profiles of all 34 healthy volunteers studied (in grey). Note that 
the PMV-LV profiles of all healthy volunteers present the same behavior and collapse within a narrow band of variability. 
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Figure 3: Temporal enstrophy maps in the LV over E-filling in sample 4 cardiac patients. For visual clarity, only 2D cross-
sectional views in a standard four-chambers view are presented out of the computed 3D time-varying enstrophy volume maps. 
Enstrophy maps are presented over 5 sample time-points spanning over the E-filling duration. Please note that the quantitative 
results of vortical flow profile are computed over the entire 3D time-varying enstrophy maps. As in Figure 1, presented enstrophy 
values are dimensionless. All enstrophy scales are normalized to the scale of the healthy volunteer to provide the same color scale 
for all presented cases. Color coding from blue (minimum) to red (maximum).  
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Distinct PMV-LV profile signatures of MV versus LV abnormalities in the studied example 
patients 
Figure 2b shows the PMV-LV profiles corresponding to the 5 representative patients as 
compared to PMV-LV profiles of all studied 34 healthy volunteers. Figure 3 presents the computed 
enstrophy maps of these patients in a standard four chambers cross-sectional view of the heart 
at five sample time points over E-filling (Supplementary videos 3-7 show evolution over 
complete E-filling). Table 2 presents a summary of the vortical profile’s characteristic 
parameters for each of the individual patients studied. As hypothesized, results reveal distinct 
and readily quantifiable differences in the PMV-LV vortical profiles between patients and healthy 
volunteers.  
 
Table 2. Characteristic dimensionless parameters of the dynamic vortex profile (PMV-LV) in healthy volunteers 
(N=34) and individual representative patients  
 𝑻𝒈𝒓𝒐𝒘𝒕𝒉 growth rate (𝜶)  
𝑻𝒅𝒆𝒄𝒂𝒚 decay rate (𝜷) 
𝑻𝑬𝑫𝒔𝒕𝒂𝒓𝒕 𝑻𝑬𝑫𝒆𝒏𝒅 
Healthy 
volunteers 
(N=34) 
1.23±0.25 0.80±0.17 0.96±0.39 -1.02±0.49 14 േ 9% 18 േ 9% 
HCM 
Patient 
2.69 0.37 0.90 0.86 4% 22% 
MI patient 0.42 1.88 0.18 -1.65 25% 71% 
Restricted 
Mitral valve 
patient with 
dilated LV 
size patient 
3.08 0.30 4.41 -0.18 8% 22% 
Restricted 
Mitral valve 
patient with 
normal size 
LV patient 
2.79 0.33 2.27 -0.33 10% 26% 
DCM 
patient 
 
0.37 1.33 0.34 -0.59 52% 80% 
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Discussion 
Using in-vivo 4D Flow MRI-derived dynamic enstrophy mapping, this study elucidates a bi-
phasic vortical flow evolution over the E-filling in the healthy LV. This bi-phasic behavior is 
characterized by a vortical growth phase followed by a vortical decay phase. To our knowledge 
this is the first in vivo study to use enstrophy to characterize vortical flow evolution in the LV. A 
standardized profile of vortical flow evolution is derived as a function of LV enstrophy density 
relative to the MV vorticity discharge over the E-wave. The derived profile parameters 
quantitatively characterize the revealed bi-phasic behavior of vortical flow evolution by means of 
coupled MV-LV hemodynamics. Hence, enabling a comprehensive analysis of diastolic vortical 
flow evolution. Consistent vortical evolution (PMV-LV) profile parameters are found over all healthy 
volunteers and distinct alterations observed in the example patients studied. 
Bi-phasic vortical flow profile and relation to MV-LV hemodynamic coupling in healthy 
volunteers 
 Previous studies showed that vortical flow emerges from the MV (1, 2, 14, 21, 22) and 
progresses inside the LV over E-filling (3, 4, 6, 11, 16, 17, 23). As such, vortical flow dynamics 
over E-filling could serve as a linkage between MV and LV hemodynamics. Therefore, in this 
work, we aimed to derive a dimensionless profile that links both MV and LV hemodynamics 
through vortical flow evolution to allow a standardized analysis of MV-LV hemodynamic 
coupling.  To achieve such profile, we needed to define a standardized measure of vortical flow 
dynamics from the MV and link it to an appropriate measure of vortical flow evolution from the 
LV. Importantly, such measures needed to be time-varying and able to characterize fluid-
dynamic properties of vortical flow including formation and dissipation. With regard to MV 
vortical dynamics, we used vortex formation/progression time (indicated here as TMV), previously 
introduced by Gharib et al (1, 15) that characterizes the vorticity discharge from MV as function 
of the MV geometry (diameter) and the dynamic inflow velocity over E-filling. Hence, providing 
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an appropriate time-varying index of vorticity discharge from MV over E-filling that also serves 
as a dimensionless time-scale (15). With respect to LV vortical flow dynamics, we used 
enstrophy mapping of the 4D Flow MRI-derived flow field. Enstrophy is an important fluid 
dynamics quantity that is known to characterize vortical flow evolution and dissipation (20, 24, 
25). Therefore, enables characterization of the complex dynamic vortical flow behavior in the 
LV. For an intuitive analogy, relation of enstrophy to vorticity (curl of velocity) is analogous with 
that of kinetic energy to velocity i.e. enstrophy could be, loosely, thought of as a measure of 
vortical flow energy therefore able to characterize growth and dissipation/decay of vortical flow.  
 In the healthy LV, prior to peak E-filling, results of our enstrophy maps are consistent 
with previous studies of vortical flow formation in the LV including the formation of a vortical ring 
structure (1, 3-5, 14). However, following peak E-filling, a major finding of the enstrophy maps in 
this study is the observation of a vortical decay phase in all healthy volunteers studied that has 
not been characterized before in vivo. Therefore, our results in the healthy volunteers reveal 
that that the evolution of vortical flow over E-filling is not only dominated by the formation of the 
vortical flow from the MV (1, 21), but rather has a more complex bi-phasic behavior involving 
growth and decay of the vortical flow. These findings support our hypothesis that vortical flow 
evolution in the LV is a result of a hemodynamic coupling between MV inflow and LV wall 
geometry dynamics with MV inflow dynamics gives rise to the formation of the vortical flow and 
impacts its growth (1, 3, 4) while LV wall dynamics governs its following decay. 
 Notably, our in-vivo results support the recent computational and in-vitro experimental 
studies that indicated that the ensuing interaction of vortical flow with the surrounding 
dynamically evolving LV geometry during diastole influences the temporal evolution of the 
vortical blood flow (3, 11, 13). Our results show that, with 𝑻𝒈𝒓𝒐𝒘𝒕𝒉 ൌ1.23±0.25 vortical flow in the 
healthy LV stops its growth phase at a time-point near peak E-filling (start of inflow 
deceleration).  
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 Recent in-vivo studies (16, 17) showed, using Lagrangian Coherent Structures 
technique (LCS), that the LV vortex boundary follows the endocardial boundary which agrees 
with our results herein. While these studies provided a better understanding of LV vortical 
formation, it is not straightforward to compare LCS dynamics across subjects. We extend the 
knowledge from previous studies by providing a standardized method to quantify the evolution 
(not only formation) of vortical flow and linking it to MV-LV hemodynamics among studied 
subjects. We showed herein that the previously reported proximity of vortical flow to the LV 
boundary in the healthy LV (16, 17)  induces a vortical decay phase that has not been reported 
before. A potential explanation of the discrepancy on the revelation of the decay phase in our 
study as compared to previous studies could be, in part, due to the methodology used and the 
focus of the study. In the majority of previous studies the focus had been on characterizing the 
vortical formation properties and not on the entire evolution as in this work. Consequently, 
previous studies have used methods that are more adequate to identify or characterize vortical 
flow formation (e.g. LCS or optimal vortex formation time) (1, 16, 17) but not necessarily 
adequate or meant for characterizing vortical flow evolution in the entire diastolic E-filling. In this 
study, we used enstrophy mapping which is known to be adequate to characterize vortical flow 
evolution properties including formation and dissipation (20, 26) to serve our focus on studying 
the evolution of vortical flow in the LV.  
 
Vortical PMV-LV profile over E-filling: distinct signatures beyond vortex formation 
characteristics  
 While previous in-vivo vortex quantification parameters have been mainly devoted to 
characterization of vortex formation properties (1, 5, 6), our derived PMV-LV profile allows 
quantitative characterization of different aspects of vortical flow evolution over the entire LV. It is 
important to highlight that unlike vortex identification-based analysis (4, 16, 17) that requires 
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data thresholding to identify structures of interest, our enstrophy profile is threshold-free as it 
characterizes the entire vortical flow in the LV.  Being dimensionless and threshold-free, the 
derived PMV-LV profile allows for a standardized comparison between vortical flow dynamics and 
link to MV-LV hemodynamics between different subjects in health and disease. This is a critical 
property of PMV-LV profile, which could allow for assembling the hemodynamic characteristics in a 
large number of patients in a standardized quantitative manner. Therefore, PMV-LV profile may 
potentially allow in the future to identify early blood flow markers in heart disease. 
Our pilot results in the studied patients clearly show the feasibility of the derived vortical 
profile in detecting distinct quantifiable differences in PMV-LV profile parameters depending on the 
cardiac abnormality as compared to all healthy volunteers studied.  Importantly, results 
noticeably show that cardiac valvular and/or ventricular abnormalities do not only affect the 
formation/growth phase of vortical flow as has been the main focus of previous research (1, 4-
6). Instead, valvular and or ventricular abnormalities are shown to affect different characteristics 
of vortical flow evolution manifested in altered PMV-LV growth and decay parameters. Enstrophy 
maps show a considerably increased enstrophy density in the mitral inflow discharge in the 
HCM patient, restricted MV patient with dilated LV size and restricted MV patient with relatively 
normal LV size (Figure 3 Supplementary Movie 2, 4, 5). That is quantitatively reflected in the 
PMV-LV profile of these patients by a considerably prolonged (2-3 time) 𝑇௚௥௢௪௧௛ compared to 
healthy volunteers.  Notably, while these patients show similar growth parameters, their decay 
parameters, which cannot be inferred from formation properties alone, differ substantially 
leaving each of the patients with a distinct PMV-LV profile signature. 
Both MI and DCM patients show a reduced vortical growth time. Nevertheless, these 
patients show distinctly altered decay properties from healthy volunteers and from each other 
(Figure 3, Supplementary Movie 3, 6). A TEDend of 71% in the MI patient and 80% in the DCM 
patient indicate that the vast majority of the discharged vortical flow is retained in the ventricle 
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by the end of E-filling demonstrating complex vortical flow in the ventricle. A TEDstart of  25% in 
the MI patient and 52% in the DCM patient indicate that large amount of vortical flow density 
has retained in the ventricle at end-systole which might contribute to increased levels of 
hemodynamic energy losses (7, 9). 
 While our feasibility results are clearly encouraging, caution need to be taken in 
interpreting such early results or extrapolating them to other patients. Follow-up cohort-based 
studies are needed to further confirm such results and to understand the link to cardiac function.  
  
Potential Clinical implications 
Altered LV or MV geometrical or dynamic properties due to heart disease would impact the vortical flow 
evolution as reflected in altered characteristics of the derived PMV-LV profile relative to that of the healthy 
heart. Mitral valvular impairments or deformations would adversely impact the characteristic of vortical 
growth parameters in the PMV-LV profile in a similar manner to that exemplified in the pilot patients studied 
herein i.e. the HCM patient and the two patients with restricted MV opening (Figure 3). Meanwhile, LV 
geometry deformations including myocardial stiffness, impaired relaxation or wall motion abnormalities 
such as those seen in cardiomyopathy(27), physiological LV remodeling as in healthy athletes or 
pathological remodeling such as in patients after myocardial infarction or LV hypertrophy(28)  would alter 
the flow-structure interaction potentially affecting vortical decay behavior as reflected in altered PMV-LV 
profile decay parameters in a similar manner to that shown in the example MI and DCM patients 
explained above. A combination of valvular and ventricular abnormalities can be present in different heart 
diseases as in LV remodeling after ischemic mitral regurgitation (29), cardiomyopathy patients (30) or 
diastolic dysfunction (31). Such combined MV-LV abnormalities could be quantitatively characterized by 
PMV-LV profile as exemplified in the example patient herein presented with both restricted MV and LV 
dilation showing distinct alteration in both the growth and decay parameters of PMV-LV profile. As such, 
intra-cardiac vortical flow evolution as characterized by the PMV-LV profile could enable a deeper 
understanding of the association between valvular and ventricular health in different heart diseases. Our 
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results could pave the way to better detection tools of the coupling between valvular and ventricular 
remodeling and progression as reflected in vortical flow evolution. Furthermore, provided vortical flow 
analysis methodology could lead to an objective assessment of the effectiveness of treatment strategies 
for cardiac diseases (e.g. Mitral valve repair)(32, 33). Future studies are needed, however, to reveal how 
specific pathophysiological events in different cardiac diseases affect vortical flow evolution and 
association to cardiac function. Moreover, our revealed bi-phasic vortical flow dynamics can be an 
important step to guide the design of accurate in-vitro experiments and numerical in-silico patient-specific 
simulations that resemble realistic cardiac hemodynamics(33). 
Limitations 
 A limitation of this study is relatively small number of subjects. However, our results 
show consistent behavior with a narrow band of variability in all studied healthy subjects which 
could further emphasize the reliability of our results. While only five example patients were 
studied, the aim was not to provide health outcomes of these patients. Instead, these patients 
were carefully chosen with various MV and LV abnormalities to experimentally illustrate the 
feasibility of the method to pave the way for future cohort-specific studies using our 
methodology for investigating MV-LV hemodynamic coupling and its relation to cardiac function. 
The derived PMV-LV profile can be considered as a global quantification method i.e. it shows that 
different enstrophy density is present but does not identify the spatial distribution of enstrophy 
within the LV. However, for a localized analysis, the global-based analysis by PMV-LV profile 
could be readily accompanied by the presented enstrophy maps to identify enstrophy density in 
different regions of the heart. 4D Flow MRI was acquired without respiratory gating to allow a 
reasonable acquisition time (8-10 minutes). We have used this protocol in several of our 
previously published work (4, 7, 8).  It should be acknowledged, however, that lack of 
respiratory gating could potentially result in blurring in the acquired flow field and related errors. 
We have visually inspected the data and we have not identified any significant blurring. 
Furthermore, a recent publication showed that 4D flow MRI acquired without respiratory gating 
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yields comparable quantitative measurements of vortex formation to 4D flow MRI with 
respiratory gating (34). 
 4D Flow MRI includes averaging the flow field data over several cardiac cycles. This 
time-averaging would potentially smooth out the small-scale flow features and does not, 
generally, adjust for flow deviations resulting from beat to beat variability. However, it was the 
aim of this study to evaluate large-scale cardiac vortical flow patterns defined as being with 
larger size than the acquired voxels and with a longer time-span than the acquired temporal 
resolution from 4D Flow MRI (in this study a spatial resolution of 2.3mm×2.3mm×3mm-4.2 
mm and a temporal resolution of 31ms were used). Vortical flow features beyond acquired 
resolution might not be negligible but could not be captured and therefore not included in the 
provided analysis.  
In conclusion, using 4D Flow MRI, we derived a standardized profile that quantitatively 
characterizes MV-LV hemodynamic coupling through vortical flow dynamics by means of LV 
enstrophy mapping and MV vorticity discharge. This profile shows consistent bi-phasic vortical 
evolution behavior in healthy subjects characterized by a growth phase followed by a decay 
phase. Distinct quantifiable alterations were found in the derived profile of the pilot example 
patients studied with MV and LV abnormalities. These findings unravel new insights into human 
heart’s physiology and could enable a novel method to understand the coupling between the 
valvular and ventricular hemodynamics and its association with different heart diseases. Future 
studies with large cohorts are needed to reveal how specific pathophysiological events in 
different cardiac diseases affect vortical flow evolution and association to cardiac function. 
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